Coronary Heart Disease News and Research

RSS

Measuring a womans fitness gives a clearer indication of coronary artery disease than measuring obesity

Women reporting higher levels of physical fitness have fewer coronary artery disease risk factors, less coronary artery disease, and a lower risk for cardiovascular events, whereas measures of obesity are not as strongly associated with these outcomes, according to a study in the September 8 issue of JAMA

8 Sep 2004

Ezetrol co-administration with statin therapy lowers LDL cholesterol in diabetics

Results from two new clinical trials show that patients with diabetes and metabolic syndrome who are treated with ezetimibe (EZETROL®) co-administered with a statin experience greater reductions in LDL (“bad”) cholesterol, compared to patients taking a statin alone.

7 Sep 2004

Salmon fed with large amounts of omega-3 fatty acid better for cardiac patients than salmon fed with vegetable oil

A study carried out by the Heart and Lung Centre at Ullevaal Hospital in Oslo has demonstrated that domesticated salmon fed with fish oil containing a large amount of omega-3 fatty acids is better for cardiac patients than salmon fed with vegetable oil (rapeseed oil).

1 Sep 2004

Study into treatments for Britain’s number one health problem, coronary heart disease

A 12-year, 3,000-patient study into treatments for Britain’s number one health problem, coronary heart disease, has been launched this summer.

31 Aug 2004

Kiwis reverse heart disease in diabetics

New Zealand biopharmaceutical company Protemix Corporation has announced the discovery of a treatment which appears to reverse heart disease in people suffering from diabetes and may lead to a more effective intervention in a major cause of death worldwide.

30 Aug 2004

The proper use of drugs to treat heart disease reduces the need for hospital interventions

Regular attacks of chest pain induced by exercise (angina pectoris) is a common condition caused by blockages of the blood vessels that supply the heart (coronary heart disease).

29 Aug 2004

Statins (HMG-CoA reductase inhibitors), are effective long term

Statins (HMG-CoA reductase inhibitors), a class of drugs that block production of cholesterol in the liver, lower total cholesterol and LDL and are also associated with cardiovascular benefits, are effective in the long term, conclude authors of a study in this week’s issue of THE LANCET.

26 Aug 2004

Study emphasizes the importance of monitoring blood pressure and dyslipidemia in patient's with metabolic syndrome

Having three or more traits of the metabolic syndrome significantly increases the risk of dying from coronary heart disease, cardiovascular disease or any other cause, according to a study in Circulation: Journal of the American Heart Association.

25 Aug 2004

High blood pressure increased 30 percent over the last decade in the U.S.

The study found that at least 65 million Americans have hypertension, defined as blood pressure of 140/90 millimeters of mercury (mm Hg) or higher, using blood-pressure lowering medications, or having been told at least twice by a physician or other health professional that they had high blood pressure (medical history). By that definition, almost a third of U.S. adults have hypertension.

25 Aug 2004

Blueberries may lower cholesterol

New research from the U.S. Department of Agriculture shows that blueberries may lower cholesterol as effectively as a commercial drug and have the potential for fewer adverse side effects.

23 Aug 2004

Significant link between depression and the development of coronary heart disease

A study of French power company employees has found a significant link between depression and the development of coronary heart disease (CHD). The research is published today in the International Journal of Epidemiology, edited in the Department of Social Medicine at Bristol University.

23 Aug 2004

COX2 inhibitor lumiracoxib could be an effective treatment for osteoarthritis

The use of non-selective non-steroidal anti-inflammatory drugs (NSAIDs) is widespread to reduce the pain associated with osteoarthritis; however the sideeffects of these drugs can be severe, sometimes leading to gastro-intestinal ulcer complications which account for around 7000 US and 1000 UK deaths each year.

21 Aug 2004

People with type 2 diabetes could benefit from atorvastatin

Results of a randomised trial in this week’s issue of THE LANCET suggest that people with type 2 diabetes could benefit from cholesterol-lowering therapy with statins to reduce the risk of cardiovascular disease, even when they do not have high cholesterol concentrations.

20 Aug 2004

Stroke research lags far behind funding for other major causes of death in Europe

Despite being the second leading cause of death worldwide, funding for stroke research lags far behind funding for other major causes of death in Europe, according to a study in Stroke: Journal of the American Heart Association.

13 Aug 2004

Finnish company discovers over 200 new genes

Finnish company Jurilab has announced the completion of a genome-wide scan in Acute Myocardial Infarction in the East Finland Founder Population.

12 Aug 2004

Survey shows Irish happy with smoke free pubs

Results of a survey, commissioned by the Irish Department of Health and Children, show continuing strong public support for the smoke-free at work measure introduced on 29th March, 2004. The survey of 1,000 people was carried out recently by Lansdowne Market Research.

11 Aug 2004

Never mind the gills here's the oyster gonads

The researchers studied 8 Sydney rock oysters, concentrating on the levels of omega-3 fatty acids in the gills, muscles and gonads.

11 Aug 2004

Link between short-term hormone therapy (HT) and improvements in life quality for women with menopausal symptoms

An article in the current issue of the Archives of Internal Medicine explains how a computer based simulation model has found a link between short-term hormone therapy (HT) and improvements in life quality for women with menopausal symptoms. The article also points out that short-term hormone therapy may actually shorten life expectancy.

10 Aug 2004

Tobacco industry's efforts to influence the print media

A study based on the tobacco industry's own documents shows the extent of the tobacco industry's efforts to influence the print media on the health effects of secondhand smoke.

7 Aug 2004

Approval of cholesterol-lowering therapy Lipitor for the prevention of cardiovascular disease

Pfizer has announced that the U.S. Food and Drug Administration has approved its cholesterol-lowering therapy Lipitor® (atorvastatin calcium) for the prevention of cardiovascular disease by reducing heart attack risk in people with normal to mildly elevated cholesterol levels who have other cardiovascular risk factors.

5 Aug 2004